Richard Taylor

Richard Taylor is an accomplished professional with extensive experience in the pharmaceutical and biotechnology industries. Currently serving as General Manager at Amicus Therapeutics since March 2020, Taylor previously held the position of BU Head - Specialty Medicine at Ferring Pharmaceuticals, where responsibilities included P&L management for Oncology and Gastro portfolios. Taylor's expertise also encompasses a role as Business Unit Director - Biotech & Devices at Merck Serono, overseeing the local sales and marketing team in Australia and shaping commercial strategies. Earlier experiences include leadership positions at sanofi-aventis and Roche, where Taylor contributed to global marketing strategies and managed diverse therapeutic areas. Taylor's educational background includes a BSC (Hons) in Chemistry from Newcastle University and training at the Australian Institute of Company Directors.